SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 28.1 EUR 1.59% Market Closed
Market Cap: 4.2B EUR
Have any thoughts about
SCHOTT Pharma AG & Co KgaA?
Write Note

Gross Margin
SCHOTT Pharma AG & Co KgaA

34.2%
Current
35%
Average
43.8%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
34.2%
=
Gross Profit
324.2m
/
Revenue
948.6m

Gross Margin Across Competitors

Country DE
Market Cap 4.2B EUR
Gross Margin
34%
Country US
Market Cap 1.3T USD
Gross Margin
55%
Country US
Market Cap 204.9B USD
Gross Margin
41%
Country US
Market Cap 172.8B USD
Gross Margin
60%
Country KR
Market Cap 68.8T KRW
Gross Margin
50%
Country CH
Market Cap 40B CHF
Gross Margin
29%
Country US
Market Cap 37.7B USD
Gross Margin
55%
Country US
Market Cap 37.2B USD
Gross Margin
35%
Country US
Market Cap 26.9B USD
Gross Margin
59%
Country US
Market Cap 24.7B USD
Gross Margin
35%
Country US
Market Cap 23B USD
Gross Margin
64%

Profitability Report

View the profitability report to see the full profitability analysis for SCHOTT Pharma AG & Co KgaA.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
34.2%
=
Gross Profit
324.2m
/
Revenue
948.6m
What is the Gross Margin of SCHOTT Pharma AG & Co KgaA?

Based on SCHOTT Pharma AG & Co KgaA's most recent financial statements, the company has Gross Margin of 34.2%.